Andrew Park

Jul 9, 2024 | onlinelibrary.wiley.com | Ariel Brown |Andrew Park |Nnenna G. Agim |Katherine Gordon

1 INTRODUCTION Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), blistering skin and mucosal eruptions, remain ill-defined in pediatric patients.1 Though guidelines exist, much data are still needed to optimize patient care.2 Emerging new classification for SJS/TEN caused by drugs simplifies clinical diagnostic criteria into a single diagnosis, “drug-induced epidermal necrolysis” (DEN).3 In this report, when SJS/TEN are grouped, the terminology DEN will be used.